BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 13 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 15 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 15 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 13 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 15 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 15 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
AlphaGraphs

Macy’s stock drops despite earnings beat

Macy’s Inc. (M) beat analyst expectations on sales and earnings numbers for the second quarter of 2018, despite sales seeing a slight decline from the prior-year period. The company also raised its earnings outlook for the full year of 2018. The stock, however, dropped 5% in premarket trade. The retailer reported net sales of $5.57 billion […]

August 15, 2018 2 min read

Macy’s Inc. (M) beat analyst expectations on sales and earnings numbers for the second quarter of 2018, despite sales seeing a slight decline from the prior-year period. The company also raised its earnings outlook for the full year of 2018. The stock, however, dropped 5% in premarket trade. The retailer reported net sales of $5.57 billion […]

· August 15, 2018

Macy’s Inc. (M) beat analyst expectations on sales and earnings numbers for the second quarter of 2018, despite sales seeing a slight decline from the prior-year period. The company also raised its earnings outlook for the full year of 2018. The stock, however, dropped 5% in premarket trade.

The retailer reported net sales of $5.57 billion for Q2 2018, down 1.1% from the same period last year. Comparable sales on an owned basis were flat – while, on an owned plus licensed basis, they were up 0.5%. Comp sales on an owned plus licensed basis beat market estimates.

Net income attributable to shareholders was $166 million or $0.53 per share compared to $111 million or $0.36 per share last year. Adjusted net income was $185 million or $0.59 per share.

Macy's second quarter 2018 earnings
Macy’s Q2 2018 Earnings Infographic

Macy’s revised its guidance for full-year 2018. The company now expects adjusted diluted EPS to be $3.95 to $4.15. Total sales growth is expected to range from flat to a 0.7% increase. Comparable sales on an owned plus licensed basis are expected to increase between 2.1% to 2.5%. Comp sales on an owned basis are expected to be 20 basis points to 30 basis points below comp sales on an owned plus licensed basis.

Macy’s saw strength across all its operating divisions – Macy’s, Bloomingdale’s and Bluemercury. The company’s brick & mortar business along with its online business performed well during the quarter, helped by the strategic initiatives it has been undertaking over the past couple of months. Despite this, sales are still seeing pressure from shifts in consumer trends and Amazon’s strong e-commerce presence.

ADVERTISEMENT

Related: Macy’s Q2 2018 Earnings Transcript

Related: Earnings Preview: Will Macy’s continue its mojo?

Related: Macy’s Q1 2018 Earnings Infographic

ADVERTISEMENT
ADVERTISEMENT